Abstract
The incidence rate of spinal infections has been rising in last decades, and despite the advances in medicine, they still represent a therapeutic challenge, especially when related to spinal implants. The majority of spinal infections in developed world are caused by pyogenic bacteria, with Staphylococcus aureus as a leading cause among gram-positive cocci and Escherichia coli among gram-negative bacteria, whereas coagulase-negative staphylococci are frequently involved in implant-associated spinal infections. Implant-associated spinal infections are caused by bacteria capable of biofilm production on the implant surface rendering them resistant to majority of antimicrobial drugs. Spinal infections in patients without implants can be treated conservatively with pathogen-directed antimicrobial therapy, whereas in implant-associated spinal infections combined surgical and antibiotic therapy is necessary. Empiric antimicrobial treatment of spinal infections without microbiological diagnosis should be discouraged in the era of drug resistant pathogens.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: European Journal of Orthopaedic Surgery & Traumatology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.